Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Aug 4, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1034842
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 78
News 8 of 204
- 8-K Quarterly results Aug 4, 2026
- 8-K Leadership change Jul 1, 2026
- 8-K Acquisition or disposal closed Jun 17, 2026
- 8-K Leadership change May 20, 2026
- 8-K Significant contract May 12, 2026
- 8-K Quarterly results May 5, 2026
- 8-K Current report on a material event Apr 21, 2026
- 8-K Quarterly results Mar 3, 2026
Prospectuses and Registrations 8 of 50
- S-8 Registration statement for an employee plan Aug 4, 2026
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-8 Registration statement for an employee plan Aug 6, 2024
- S-3 Shelf registration statement Aug 2, 2024
- S-8 Registration statement for an employee plan Aug 1, 2023
- S-8 Registration statement for an employee plan Mar 7, 2023
- S-8 Registration statement for an employee plan Aug 3, 2022
- S-8 Registration statement for an employee plan Mar 1, 2022
Proxies 8 of 43
- DEFA14A Extra proxy material Apr 3, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2026
- DEFA14A Extra proxy material Apr 10, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2025
- DEFA14A Extra proxy material Apr 10, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2024
- PRE 14A Preliminary proxy statement Mar 29, 2024
- DEFR14A May 15, 2023
Ownership 8 of 559
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Jul 10, 2026
- 4 Insider reported a trade Jun 24, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 66
- ARS Annual report sent to shareholders Apr 10, 2025
- EFFECT Notice that a registration became effective Aug 9, 2024
- CORRESP Reply to SEC staff Aug 8, 2024
- UPLOAD Comment letter from SEC staff Aug 7, 2024
- ARS Annual report sent to shareholders Apr 10, 2024
- ARS Annual report sent to shareholders Apr 14, 2023
- EFFECT Notice that a registration became effective May 3, 2022
- POSASR Mar 1, 2022
Everything here comes from Rigel Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.